Limited sampling strategy to predict AUC of CYP3A phenotyping probe mosapride in rats
碩士 === 國立成功大學 === 臨床藥學研究所 === 97 === Introduction Cytochrome P450 3A (CYP3A) is an important subfamily of drug- metabolizing enzymes. In humans, it is responsible for metabolizing numerous drugs across several therapeutic classes. Interindividual variability in the expression and activity of CYP3A i...
Main Authors: | Ching-yun Wei, 魏敬云 |
---|---|
Other Authors: | Ching-ling Cheng |
Format: | Others |
Language: | zh-TW |
Published: |
2009
|
Online Access: | http://ndltd.ncl.edu.tw/handle/21124511543327888281 |
Similar Items
-
Feasibility of mosapride as an in vivo probe of CYP3A activity in rats
by: Ya-Wen Chang, et al.
Published: (2008) -
Mosapride as a hepatic CYP3A probe in rats:compared with the reference probe midazolam
by: Pei-HsuanJen, et al.
Published: (2010) -
Mosapride as a hepatic CYP3A probe in rats: application to rilpivirine pharmacokinetics
by: Wen-HanChen, et al.
Published: (2013) -
Mosapride as a hepatic CYP3A probe in rats: application to rivaroxaban pharmacokinetics
by: Chien-LungTu, et al.
Published: (2013) -
Assessing Aging-Effect on CYP3A Activity in Rats with Probe Substrate Mosapride
by: Yin-YinTung, et al.
Published: (2016)